No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy No effect on anxiety but significantly less patient-rated pain Jan 12, 2024
Trump-Era Conscience Rule Rescinded; Lloyd Austin's Cancer; Sinead O'Connor's Death Health news and commentary from around the Web gathered by MedPage Today staff Jan 10, 2024
More Evidence Linking ADT for Prostate Cancer to Adverse Neurocognitive Effects Meta-analysis shows increased risk of dementia, Parkinson's, depression Jan 09, 2024
Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Risk No excess high-grade or overall prostate cancer risk in TRAVERSE with 33 months of follow-up Dec 27, 2023
TULSA Effective in Controlling Prostate Cancer Long-Term At 5 years, median PSA was reduced by 90% Dec 05, 2023
Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomy Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparities A "local heroes effect" can better reach communities of color Nov 09, 2023
Transitioning Cancer Survivors Away From Oncologic Care It's time for a new model of care Nov 03, 2023
Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold Nov 01, 2023
Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPC Time to radiographic progression doubled with 177Lu-PSMA-617 Oct 25, 2023
Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfers Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
Should Older Prostate Cancer Patients Jump Off the Active Surveillance Train? It's time for clear guidelines Oct 18, 2023
SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancer Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancer Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
Global Incidence of Early-Onset Cancer Has Surged Since 1990 Early-onset breast cancer has highest incidence and mortality rates Sep 06, 2023
Prostate Cancer Is Not Just an 'Old Man's Disease' Spreading this message can save lives Sep 02, 2023
Does Cancer Screening Actually Extend Lives? A series of articles look at whether the benefits for the few warrant the harms for the many Aug 28, 2023
Multi-Cancer Early Detection: 20th-Century Fiction Becomes Reality These tests could soon become a valuable addition to current cancer screening tools Aug 01, 2023
MR-Guided Adaptive SBRT Tied to Reduced Side Effects in Prostate Cancer However, this technique requires more time and resources than standard techniques Jul 24, 2023
FDA OKs Olaparib-Abiraterone for Metastatic Prostate Cancer Approval limited to BRCA-positive subset Jun 01, 2023
Lumpers vs Splitters: Categorizing Prostate Cancer Should very low-risk and low-risk be combined into one? May 19, 2023
Enzalutamide-ADT Cuts Risk for Disease Spread in Nonmetastatic Prostate Cancer Combo has potential to be new standard of care in patients with high-risk BCR, expert says Apr 30, 2023
FDA Panel Rejects Broad Olaparib Indication in Metastatic CRPC ODAC votes that olaparib-abiraterone combination should be restricted to BRCA-positive subset Apr 28, 2023
Robust PSA Drops With Radionuclide Therapy in Castration-Resistant Prostate Cancer All but one patient had a PSA decline after a fractionated dose of 225Ac-J591 Apr 18, 2023
Older Men Still Overscreened for Prostate Cancer, Survey Says PSA screening rates over 50% for men 70 and up, despite USPSTF recommendations against it Apr 11, 2023
Escalated ADT Falls Short in Men With High-Risk Features After Prostatectomy But add-on abiraterone and apalutamide may offer some benefits in those with higher PSA Feb 18, 2023
Add-On Olaparib Continues to Show Benefit in First-Line Treatment of mCRPC Final PROpel analysis also shows trend toward overall survival improvement with PARP inhibitor Feb 17, 2023
Adding Talazoparib to Enzalutamide Boosts PFS in Metastatic Prostate Cancer Combination achieved a 37% reduction in risk of progression, death versus ARPI alone Feb 17, 2023
Rucaparib Gets a Win in Metastatic Castration-Resistant Prostate Cancer Benefit in selected patients seen over physician's choice of docetaxel or second-generation ARPI Feb 16, 2023
If It Resembles Cancer but Doesn't Act Like Cancer, Is It Cancer? Physicians must consider patient perspectives on the Gleason 6 debate Feb 16, 2023
Short-Course Apalutamide to Reduce Active Surveillance Attrition in Prostate Cancer Editorialists question whether any intervention violates principles of surveillance Jan 17, 2023
MRI-Guided Focused Ultrasound Eases Pain From Bone Metastases More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
MRI-Targeted Biopsy for Prostate Cancer Reduces Risk of Overdiagnosis Though at the cost of delayed diagnosis of some clinically significant cancers Dec 07, 2022
Can Oncologists Reduce the Suicide Risk in Their Prostate Cancer Patients? Barriers exist in identifying risk, but strategies are available Dec 06, 2022
Metastasis-Directed Therapy May Delay ADT in Advanced Prostate Cancer Surgery or radiation delayed initiation of systemic therapy by 18 months Nov 29, 2022
Primary Care Visits Prior to Cancer Diagnosis Tied to Lower Mortality Most benefit with annual visits, but even some use linked to better outcomes Nov 16, 2022
Could a Plant-Based Diet Benefit Men's Health Below the Belt? Analysis suggests protective nature of veggie-heavy diet in prostate cancer and more Oct 30, 2022
Metastasis-Directed Therapy for Prostate Cancer Increases PFS, Time off Hormones Radiotherapy led to "dramatic" slowing of progression, increased time with normal testosterone Oct 27, 2022
Sexual Health Not Part of Discussion for Women Undergoing Brachytherapy Much less likely than men to be queried about sexual function when receiving treatment Oct 25, 2022
Shorter Course of Radiation Therapy Proves Mettle in High-Risk Prostate Cancer Hypofractionation matches standard RT for survival and toxicity in a third less time Oct 25, 2022
